Fusion Antibodies plc (AIM:FAB)

Fusion Antibodies Balance Sheet

Financials in millions GBP. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	0.36	1.2	0.2	2.05	2.69
Cash & Short-Term Investments	0.36	1.2	0.2	2.05	2.69
Cash Growth	-70.06%	514.87%	-90.48%	-23.72%	74.76%
Accounts Receivable	0.33	0.44	0.36	0.78	0.59
Other Receivables	0.07	0.05	0.34	0.25	0.19
Receivables	0.4	0.49	0.7	1.02	0.78
Inventory	0.27	0.46	0.54	0.59	0.48
Prepaid Expenses	0.23	0.11	0.26	0.62	0.76
Total Current Assets	1.26	2.26	1.69	4.28	4.71
Property, Plant & Equipment	0.06	0.16	0.38	0.63	1.12
Other Intangible Assets	-	-	-	-	0
Total Assets	1.32	2.42	2.06	4.92	5.83
Accounts Payable	0.37	0.56	0.48	0.47	0.34
Accrued Expenses	0.21	-	0.31	0.63	0.44
Current Portion of Leases	0.02	0.02	0.04	0.07	0.16
Other Current Liabilities	0.02	-	0.05	0.05	0.05
Total Current Liabilities	0.62	0.58	0.88	1.21	1
Long-Term Leases	-	0.02	0.04	0	0.07
Other Long-Term Liabilities	0.03	0.02	0.02	0.02	0.02
Total Liabilities	0.65	0.63	0.94	1.23	1.08
Common Stock	4.2	3.82	1.04	1.04	1.02
Additional Paid-In Capital	7.94	7.74	7.65	7.65	7.55
Retained Earnings	-11.47	-9.77	-7.56	-5	-3.82
Shareholders' Equity	0.67	1.79	1.12	3.68	4.75
Total Liabilities & Equity	1.32	2.42	2.06	4.92	5.83
Total Debt	0.02	0.04	0.08	0.07	0.23
Net Cash (Debt)	0.34	1.16	0.12	1.98	2.46
Net Cash Growth	-70.67%	863.33%	-93.94%	-19.38%	112.27%
Net Cash Per Share	0.00	0.02	0.00	0.08	0.10
Filing Date Shares Outstanding	104.9	95.37	26.01	26.01	25.61
Total Common Shares Outstanding	104.9	95.37	26.01	26.01	25.61
Working Capital	0.64	1.68	0.81	3.07	3.71
Book Value Per Share	0.01	0.02	0.04	0.14	0.19
Tangible Book Value	0.67	1.79	1.12	3.68	4.75
Tangible Book Value Per Share	0.01	0.02	0.04	0.14	0.19
Machinery	2.68	2.68	2.67	2.66	2.43
Leasehold Improvements	0.84	0.84	0.84	0.81	0.78

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.